Organogenesis Holdings (ORGO) Short term Debt (2017 - 2024)

Organogenesis Holdings' Short term Debt history runs 8 years deep, the most recent figure standing at $6.0 million for Q3 2024.

• In Q3 2024, Short term Debt rose 8.77% year-over-year to $6.0 million; the TTM figure through Sep 2024 stood at $6.0 million (up 8.77% YoY), while the FY2023 annual figure was $5.5 million, up 20.89% from the prior year.
• Short term Debt was $6.0 million for Q3 2024 at Organogenesis Holdings, up from $5.8 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $22.5 million in Q2 2021 to a low of $1.7 million in Q1 2020.
• Historically, Short term Debt has averaged $7.1 million across 5 years, with a median of $5.5 million in 2023.
• Biggest YoY gain for Short term Debt was 912.3% in 2021; the steepest drop was 84.06% in 2021.
• A 5-year view of Short term Debt shows it stood at $16.7 million in 2020, then slumped by 84.06% to $2.7 million in 2021, then jumped by 70.86% to $4.5 million in 2022, then gained by 20.89% to $5.5 million in 2023, then rose by 8.71% to $6.0 million in 2024.
• The last three Short term Debt figures came in at $6.0 million (Q3 2024), $5.8 million (Q2 2024), and $5.5 million (Q1 2024), per Business Quant data.